Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Technol Cancer Res Treat. 2015 Jul 1;15(5):651–660. doi: 10.1177/1533034615593191

Table 1.

Patient History and Treatment Information.

Patient No. Age Primary Site Tumor Staging Prescription Dose, Gy GTV Volume, cm3 6-Month Follow-Up
1 63 Left breast T1N0M0 15 0.84 NED
2 73 Right breast T1N0M0 15 0.45 NED
3 59 Left breast T1N0M0 15 0.55 NED
4 56 Left breast T1N0M0 15 0.71 NED
5 62 Left breast T1N0M0 15 0.94 NED
6 73 Left breast T1N0M0 15 1.18 NED
7 60 Left breast T1N0M0 18 0.33 NED
8 62 Left breast T1N0M0 18 0.52 NED
9 77 Left breast T1N0M0 18 1.69 NED
10 63 Right breast T1N0M0 21 0.91 NED
11 58 Right breast T1N0M0 21 0.23 NED
12 59 Left breast T1N0M0 21 0.17 NED
13 70 Left breast T1N0M0 21 0.12 NED
14 68 Right breast T1N0M0 21 0.67 NED
15 64 Right breast T1N0M0 21 0.60 NED

Abbreviation: NED, no evidence of disease.